TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07491029: A Multi-center, Randomized, Double-blind, Prospective, Superiority Clinical Trial to Evaluate the Safety and Effectiveness of Artificial Intelligence-based Customized Transcranial Direct Current Stimulation Using MR Imag

Sponsor: NEUROPHET · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 116 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$12,416,000

Rescue Site Savings

+$8,186,800

Unlock Full NCT07491029 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07491029 Rescue Dossier →